Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03084367 · ClinicalTrials.gov registry record
Physiologic Assessment of Coronary Stenosis Following PCI
A clinical trial, sponsored by Volcano Corporation.
- Completed
- Registry status
- 500
- Enrollment target
NCT03084367: Completed study, sponsored by Volcano Corporation.
NCT03084367 is a clinical trial that has completed, run by Volcano Corporation. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03084367 has completed, sponsored by Volcano Corporation.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).
Primary Outcome
Residual ischemia is defined as iFR measurement \<0.90 after operator-assessed angiographically successful PCI (residual diameter stenosis \<50% in any treated lesion in the target vessel) This outcome describes the number of participants that had a residual ischemia (defined as iFR\<0.90) after a PCI that appeared to be successful based on angiography.
Interventions
- DIAGNOSTIC_TEST iFR pullback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-06-20 |
| Est. Completion | 2020-02-18 |
What the finished NCT03084367 record still lists
NCT03084367 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which iFR pullback is the first listed.
NCT03084367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03084367 about?
NCT03084367 is a clinical study titled "Physiologic Assessment of Coronary Stenosis Following PCI". This is a pilot study designed to assess the relationship between iFR (instantaneous wave-free ratio) pullback and the distribution of coronary atheroma/stenoses as assessed by Quantitative Coronary Angiography (QCA) post angiographically successful PCI (Percutaneous Coronary Intervention).
What is the current status of trial NCT03084367?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2017-06-20. Estimated completion is 2020-02-18.
What interventions are being tested in trial NCT03084367?
The interventions under investigation include: iFR pullback (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03084367?
This trial is sponsored by Volcano Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI